Resultats globals: 4 registres trobats en 0.07 segons.
Articles, 1 registres trobats
Documents de recerca, 3 registres trobats
Articles 1 registres trobats  
1.
15 p, 877.1 KB Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis : APLIOS, a randomized phase-2 study / Bar-Or, Amit (University of Pennsylvania) ; Wiendl, Heinz (University of Münster) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Alvarez, Enrique (University of Colorado) ; Davydovskaya, Maria (Pirogov Russian National Research Medical University) ; Delgado, Silvia (University of Miami) ; Evdoshenko, Evgeniy P. (St Petersburg Center for Multiple Sclerosis and Other Autoimmune Diseases) ; Giedraitiene, Natasa (Vilnius University) ; Gross-Paju, Katrin (Institute of Health Care Technology) ; Haldre, Sulev (University of Tartu) ; Herrman, Craig E. (JWM Neurology) ; Izquierdo, Guillermo (Hospital Vithas Sevilla) ; Karelis, Guntis (Riga East University Hospital) ; Leutmezer, Fritz (Medical University of Vienna) ; Mares, Miroslav (Pardubice Regional Hospital) ; Meca-Lallana, Jose Eustasio (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ; Mickeviciene, Dalia (Lithuanian University of Health Sciences) ; Nicholas, Jacqueline (Riverside Methodist Hospital) ; Robertson, Derrick S. (University of South Florida) ; Sazonov, Denis V. (Department of Clinical Trials FSBIH SDMC of FMBA of Russia) ; Sharlin, Kenneth (Sharlin Health and Neurology) ; Sundaram, Bharathy (Texas Institute for Neurological Disorders) ; Totolyan, Natalia (Pavlov First State Medical University of St. Petersburg) ; Vachova, Marta (Teplice Hospital) ; Valis, Martin (Charles University) ; Bagger, Morten (Novartis) ; Häring, Dieter A. (Novartis) ; Ludwig, Inga (Novartis) ; Willi, Roman (Novartis) ; Zalesak, Martin (Novartis) ; Su, Wendy (Novartis) ; Merschhemke, Martin (Novartis) ; Fox, Edward J. (Central Texas Neurology Consultants PA) ; Universitat Autònoma de Barcelona
Background: Ofatumumab, the first fully human anti-CD20 monoclonal antibody, is approved in several countries for relapsing multiple sclerosis (RMS). Objective: To demonstrate the bioequivalence of ofatumumab administered by an autoinjector versus a pre-filled syringe (PFS) and to explore the effect of ofatumumab on B-cell depletion. [...]
2022 - 10.1177/13524585211044479
Multiple sclerosis, Vol. 28 Núm. 6 (2022) , p. 910-924  

Documents de recerca 3 registres trobats  
1.
1 p, 181.2 KB The importance of bioequivalence in generic drugs. An example: Clopidogrel / Millet Rafel, Silvia ; Vivas Sabido, Nuria María, dir. (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Biotecnologia [815]  
2.
1 p, 2.3 MB Bioequivalence : prerequisite for generic drugs / Muriel Masanes, Mireia ; Vivas Sabido, Nuria María, dir. (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Grau en Microbiologia [816]  
3.
1 p, 55.9 KB Bioequivalence and generic medicinal products : the levonthyroxine case / Torres Moral, Teresa ; Vivas Sabido, Nuria María, dir. (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Grau en Microbiologia [816]  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.